Evidence map›Paper›PMID 37958957›Full record

ReviewInternational journal of molecular sciences2023

Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).

Somayeh Vafaei, Michał Ciebiera, Mervat M Omran, Mohammad Mousaei Ghasroldasht, Qiwei Yang, Tanya Leake, Rochelle Wolfe, Mohamed Ali, Ayman Al-Hendy

2 registry-linked trialsAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06768086 completednot on this mapstarted 2025, after this paper: background citation

3 Months Preoperative Administration of Eutris Plus Prior Hysteroscopic Myomectomy: a Pilot Study

Typeobservational_patient_registrySponsorCentro di Ricerca Clinica SalentinoRan2025 to 2025Enrolled90ConditionsUterine Fibroids, Hysteroscopic Myomectomy, Treatment Compliance, Patient ComplianceArmsHysteroscopic myomectomy
NCT07647198 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

FATIMA Trial: EGCG and Vitamin D3 for Secondary Prevention of Uterine Fibroids

TypeinterventionalSponsorSheikh Shakhbout Medical CityRan2026 to 2029Enrolled240ConditionsUterine Fibroids (Leiomyoma)ArmsVitamin D and Green Tea, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Therapeutic Potential of Solanum macrocarpon in Uterine Leiomyoma: In Vivo and In Silico Approaches.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Somayeh VafaeiDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-0758-2133
Michał CiebieraSecond Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, 00-189 Warsaw, Poland.ORCID 0000-0001-5780-5983
Mervat M OmranDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
Mohammad Mousaei GhasroldashtDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-0279-6730
Qiwei YangDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-7131-8946
Tanya LeakeThe White Dress Project, Atlanta, GA 30309, USA.
Rochelle WolfeThe White Dress Project, Atlanta, GA 30309, USA.
Mohamed AliDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-9675-6691
Ayman Al-HendyDepartment of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-8778-4447

Funding

Training the Trainers: Building Institutional Data Science Capacity to Support Health Disparities ResearchU54MD007602 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI Kevin Sean Kimbro · 2018 to 2026
$47.6M
Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sampleR01ES028615 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AL-HENDY, AYMAN, WALKER, CHERYL L. · 2017 to 2022
$5.0M
Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroidsR01HD094378 · NICHD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI AL-HENDY, AYMAN, BOYER, THOMAS G · 2018 to 2022
$4.2M
Molecular basis of MED12 in the pathogenesis of uterine fibroidsR01HD087417 · NICHD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI THOMAS G BOYER · 2017 to 2026
$3.4M
Pathological reprogramming of the m6A epitranscriptome in uterine fibroidsR01HD106285 · NICHD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI AL-HENDY, AYMAN, BOYER, THOMAS G · 2021 to 2025
$3.2M
NICHD NIH HHS R01 HD087417NICHD NIH HHS R01 HD094378NICHD NIH HHS R01 HD106285NIEHS NIH HHS R01 ES028615NIH HHS RO1 ES028615, RO1 HD094378, U54 MD007602, RO1 HD087417, and RO1 HD106285.NIMHD NIH HHS U54 MD007602
6 · The paper itself

Abstract

Uterine fibroids (UFs) are common tumors in women of reproductive age. It is imperative to comprehend UFs' associated risk factors to facilitate early detection and prevention. Simple relying on surgical/pharmacological treatment of advanced disease is not only highly expensive, but it also deprives patients of good quality of life (QOL). Unfortunately, even if the disease is discovered early, no medical intervention is traditionally initiated until the disease burden becomes high, and only then is surgical intervention performed. Furthermore, after myomectomy, the recurrence rate of UFs is extremely high with the need for additional surgeries and other interventions. This confused approach is invasive and extremely costly with an overall negative impact on women's health. Secondary prevention is the management of early disease to slow down its progression or even halt it completely. The current approach of watchful observation for early disease is considered a major missed opportunity in the literature. The aim of this article is to present an approach named the ESCAPE (Evidence-Based Approach for Secondary Prevention) of UF management. It comprises simple, inexpensive, and safe steps that can arrest the development of UFs, promote overall reproductive health, decrease the number of unnecessary surgeries, and save billions of health care systems' dollars worldwide.

Indexed as

LeiomyomaUterine MyomectomyUterine NeoplasmsFemaleHumansQuality of LifeSecondary PreventionEGCGleiomyomareproductive healthsecondary preventionuterine fibroidvitamin D3

Identifiers

PMID37958957
PMCPMC10648339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.